Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hypersensitivity × Cetirizine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Hypersensitivity 1

Interventions

Ultrasonography 2 tislelizumab 1 Mammography 1 Lenalidomide 1 Immune Checkpoint Inhibitors 1 High-Energy Shock Waves 1 Cetirizine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06039137 2024-09-25

H1-Switch

Erasmus Medical Center

Hypersensitivity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡